Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations – Yahoo Finance
Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations Yahoo FinanceNovo shares slide as drugmaker lays out post-Wegovy growth…
Generic semaglutide market shows signs of excess inventory bulge | Industry News
Pharmarack data indicates elevated stock levels across several recently launched brands amid slower-than-expected liquidation in the trade…
Ozempic may be reshaping the brain, scientists say
Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant…